The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Olanzapine 15mg Orodispersible Tablets

Accord Healthcare Ireland Ltd.PA2315/229/003

Main Information

Trade NameOlanzapine 15mg Orodispersible Tablets
Active SubstancesOlanzapine
Dosage FormOrodispersible tablet
Licence HolderAccord Healthcare Ireland Ltd.
Licence NumberPA2315/229/003

Group Information

ATC CodeN05AH Diazepines, oxazepines, thiazepines and oxepines
N05AH03 olanzapine


License statusAuthorised
Licence Issued06/08/2010
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0007-032-038
Interchangeable List DocumentPDF of Interchangeable List
« Back